47
Participants
Start Date
March 31, 2012
Primary Completion Date
October 31, 2012
Study Completion Date
October 31, 2012
Group 1 Standard of Care
Patients in this group will receive IV morphine sulfate or Sponsor-approved equivalent via PCA pump, as needed.
Group 2 EXPAREL
Patients in this group will receive 266 mg EXPAREL diluted with preservative-free 0.9% normal saline to a total volume of 30cc and administered via wound infiltration prior to wound closure. When not contraindicated, 30 mg IV ketorolac will be given at the end of surgery. If not indicated, IV non-steroidal anti-inflammatory drug (NSAID) may be substituted per the site's standard of care.
Cleveland Clinic Florida, Weston
Cleveland Clinic Ohio, Beachwood
Lead Sponsor
Registrat-Mapi
OTHER
Pacira Pharmaceuticals, Inc
INDUSTRY